查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941510

血糖值監測設備市場規模、佔有率和趨勢分析報告：按產品、性別、最終用途、地區和細分市場預測（2026-2033 年）

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Connectivity, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

血糖值監測設備市場概覽

2025年全球血糖值監測市場規模估計為155.3億美元，預計2033年將達到301.8億美元。

預計從 2026 年到 2033 年，該市場將以 8.8% 的複合年成長率成長。這個市場的主要影響因素是糖尿病盛行率的上升以及老年人口的成長，老年人更容易患上糖尿病等疾病。

此外，人們對糖尿病預防措施的意識提升以及新產品的推出也推動了市場成長。糖尿病是一種全球流行且日益嚴重的疾病，其特徵是胰臟無法有效產生胰島素，導致血糖水平升高。血糖值監測技術不僅能夠實現即時干預，也是對患者進行糖尿病及其有效管理教育的重要工具。

預計在預測期內，全球糖尿病盛行率的不斷上升將推動強勁的市場需求。根據健康指標評估實驗室（Health Metrics Assessment Lab，2023年6月）的數據顯示，目前全球有超過5億人患有糖尿病，影響所有人。糖尿病的全球盛行率為6.1%，名列十大死因與致殘原因。北非和中東地區的盛行率最高，達9.3%，預計2050年將上升至16.8%。拉丁美洲和加勒比海地區的盛行率預計將上升至11.3%。

此外，人們對糖尿病預防措施的認知不斷提高以及新產品的推出正在推動市場成長。糖尿病是一種由於胰臟無法有效產生胰島素而導致血糖值升高的疾病，是一個日益嚴重的全球性問題。根據國際糖尿病聯盟（IDF）統計，2021年全球糖尿病確診患者人數將達到約5.37億，預計2030年將達到6.43億，到2045年將達到7.83億。

血糖值監測設備在幫助糖尿病患者方面發揮著多種重要作用。首先，它們使患者和醫護人員能夠了解血糖值的升降情況，從而及時調整治療方案。此功能有助於快速辨識急性低血糖和高血糖，保障患者的健康。此外，這些設備有助於患者進行自我管理，從而更有效地控制糖尿病。而且，血糖值監測設備所採用的技術不僅有助於即時干預，還能作為糖尿病及其有效管理的重要教育工具。

糖尿病的盛行率往往老齡化增加而增加，老年人罹患糖尿病及其併發症的風險更高。隨著老年人口的成長，糖尿病高風險族群的數量也在增加，從而推動了對血糖值監測設備的需求。例如，根據美國國家糖尿病統計報告，2021年美國有2720萬65歲及以上的老年人處於糖尿病前期。研究表明，即時連續血糖值監測（CGM）設備對65歲及以上的第2型糖尿病患者有效且安全。與背景血糖值監測（BGM）相比，使用CGM的65歲及以上參與者的糖化血紅蛋白（HbA1c）水平顯著改善，血糖值控制也得到改善。這些結果凸顯了CGM設備作為有效管理老年人糖尿病的重要工具的潛在價值。

新冠感染疾病對市場產生了重大影響。它凸顯了醫療保健方面的不平等以及技術的重要性，尤其是背景血糖監測儀（BGM）。監管政策的調整（例如，放寬持續血糖值監測儀（rtCGM）的使用顯著改善了血糖控制，延長了血糖在目標範圍內的時間並降低了血糖波動，從而極大地促進了整體市場成長。

目錄

第1章調查方法和範圍

第2章血糖值監測設備市場：執行摘要

  • 市場概覽
  • 產品、連接方式和最終用途概述
  • 競爭格局概述

第3章血糖值監測設備市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場譜系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • 世界人口老化問題日益嚴重
    • 糖尿病患者人數不斷增加
    • 提高對糖尿病預防保健的認知
  • 市場限制因素分析
    • 設備高成本
  • 血糖值監測設備市場分析工具
    • 產業分析：波特五力模型
    • PESTLE分析
    • 定價分析

第4章血糖值測量設備：產品分類、估算與趨勢分析

  • 全球血糖值監測設備市場：產品差異分析
  • 全球血糖值監測設備市場規模及趨勢分析（依產品分類，2021-2033 年）
  • 自測量裝置
    • 2021-2033年市場估算與預測
    • 血糖儀
    • 測試條
    • 《採血針》
  • 連續血糖值監測設備
    • 2021-2033年市場估算與預測
    • 感應器
    • 發送器和接收器
    • 胰島素幫浦

第5章血糖值監測設備：連結性別、估算與趨勢分析

  • 全球血糖值監測設備市場：連接方式差異分析
  • 全球血糖值監測設備市場規模及趨勢分析（按連接類型分類，2021-2033 年）
  • 支援藍牙的設備
  • 支援 Wi-Fi 的設備
  • 支援近距離場通訊 (NFC) 的設備
  • USB連接裝置

第6章血糖值監測設備：依最終用途分類的估算與趨勢分析

  • 全球血糖值監測設備市場：終端用途差異分析
  • 全球血糖值監測設備市場規模及趨勢分析（依最終用途分類，2021-2033 年）
  • 醫院
  • 居家醫療
  • 診斷中心

第7章 區域業務分析

  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商和通路夥伴
    • 主要客戶
    • 主要企業市佔率分析，2025 年
Product Code: GVR-3-68038-688-2

Blood Glucose Monitoring Devices Market Summary

The global blood glucose monitoring devices market size was estimated at USD 15.53 billion in 2025 and is projected to reach USD 30.18 billion by 2033, growing at a CAGR of 8.8% from 2026 to 2033. The market is primarily influenced by the growing prevalence of diabetes and growing elderly population susceptible to conditions such as diabetes.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and increasing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. Moreover, the technology associated with blood glucose monitoring not only aids immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The rising global prevalence of diabetes is anticipated to drive strong market demand during the forecast period. According to the Institute for Health Metrics and Evaluation (June 2023), over 500 million people worldwide currently live with diabetes, impacting individuals across all demographics. With a global prevalence of 6.1%, diabetes ranks among the top 10 causes of death and disability. North Africa and the Middle East lead with a 9.3% prevalence, which is expected to increase to 16.8% by 2050. In Latin America and the Caribbean, the prevalence is projected to rise to 11.3%.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and growing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. According to the International Diabetes Federation, approximately 537 million individuals were diagnosed with diabetes in 2021, and projections indicate an anticipated rise to 643 million by 2030 and 783 million by 2045.

Blood glucose monitoring (BGM) devices play a crucial role in supporting individuals with diabetes in numerous ways. Initially, they empower both patients and healthcare professionals to identify elevated or reduced blood glucose levels, enabling timely adjustments to treatment plans. This capability serves as a protective measure by promptly confirming acute hypoglycemia or hyperglycemia, ensuring the well-being of patients. In addition, these devices enhance self-care practices, offering individuals greater control over their diabetes management. Moreover, the technology associated with blood glucose monitoring not only aids in immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The prevalence of diabetes tends to increase with age, and older adults are more susceptible to developing diabetes or experiencing complications related to the disease. As the geriatric population increases, so does the pool of individuals at risk of diabetes, creating a greater demand for blood glucose monitoring devices. For instance, based on the National Diabetes Statistics Report, in 2021, in the U.S. 27.2 million adults aged 65 years or older had prediabetes. Studies have shown that real-time continuous glucose monitoring (CGM) is effective and safe in adults aged 65 years and older with type 2 diabetes. Participants aged 65 years and above showed a significant improvement in their hemoglobin A1c (HbA1c) levels, which indicates better control of blood glucose levels when using CGM compared to blood glucose monitoring (BGM). These results underscore the potential value of CGM devices as a beneficial tool for effectively managing diabetes in the elderly population.

The COVID-19 pandemic has significantly impacted the market. The pandemic highlighted healthcare disparities and technological importance, including BGM devices. Regulatory changes, such as relaxed requirements for obtaining continuous glucose monitoring (CGM), have increased access to these devices, particularly benefiting those who can benefit from the technology. Furthermore, the use of real-time continuous glucose monitoring (rtCGM) was observed during lockdowns for improved glycemic control, reducing the time in range & glucose variability, thereby significantly boosting the overall market growth.

Global Blood Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood glucose monitoring devices market report on the basis of product, connectivity, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Traditional BGMs
    • Smart BGMs
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring (CGM) Devices
    • Sensors
    • Transmitter and Receiver
    • Insulin Pumps
    • Traditional Insulin Pumps
    • Smart Insulin Pumps
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Bluetooth-Enabled Devices
  • Wi-Fi-Enabled Devices
  • Near Field Communication (NFC) Devices
  • USB Connectivity Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Home Care
  • Diagnostic Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Connectivity Segment
    • 1.2.3. End-use Segment
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Objectives
    • 1.5.1. Objective - 1
    • 1.5.2. Objective - 2
  • 1.6. Research Methodology
  • 1.7. Information Procurement
    • 1.7.1. Purchased Database
    • 1.7.2. GVR's Internal Database
    • 1.7.3. Secondary Sources
    • 1.7.4. Primary Research
  • 1.8. Information or Data Analysis
    • 1.8.1. Data Analysis Models
  • 1.9. Market Formulation & Validation
  • 1.10. Model Details
    • 1.10.1. Commodity Flow Analysis
  • 1.11. List of Primary Sources
  • 1.12. List of Abbreviations

Chapter 2. Blood Glucose Monitoring Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products, Connectivity, and End Use Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Glucose Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising geriatric population worldwide
    • 3.4.2. Increasing number of diabetes patients
    • 3.4.3. Increasing awareness about diabetes preventive care
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of devices
  • 3.6. Blood Glucose Monitoring Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Blood Glucose Monitoring Devices: Product Estimates & Trend Analysis

  • 4.1. Global Blood Glucose Monitoring Market: Product Segment Dashboard
  • 4.2. Global Blood Glucose Monitoring Devices Market by Product Outlook
  • 4.3. Global Blood Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Self-Monitoring Devices
    • 4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Blood Glucose Meter
      • 4.4.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.4.2.2. Traditional BGMs
        • 4.4.2.2.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.4.2.3. Smart BGMs
        • 4.4.2.3.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.4.3. Testing Strips
      • 4.4.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.4.4. Lancets
      • 4.4.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.5. Continuous Blood Glucose Monitoring Devices
    • 4.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.2. Sensors
      • 4.5.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.3. Transmitter & Receiver
      • 4.5.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.4. Insulin Pumps
      • 4.5.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.5.4.2. Traditional Insulin Pumps
        • 4.5.4.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.5.4.3. Smart Insulin Pumps
        • 4.5.4.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 5. Blood Glucose Monitoring Devices: Connectivity Estimates & Trend Analysis

  • 5.1. Global Blood Glucose Monitoring Market: Connectivity Segment Dashboard
  • 5.2. Global Blood Glucose Monitoring Market: Connectivity Movement Analysis
  • 5.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by Connectivity, 2021 - 2033 (USD Million)
  • 5.4. Bluetooth-Enabled Devices
    • 5.4.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.5 Wi-Fi-Enabled Devices
    • 5.5.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.6 Near Field Communication (NFC) Devices
    • 5.6.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.7 USB Connectivity Devices
    • 5.7.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 6. Blood Glucose Monitoring Devices: End Use Estimates & Trend Analysis

  • 6.1. Global Blood Glucose Monitoring Market: End Use Segment Dashboard
  • 6.2. Global Blood Glucose Monitoring Market: End Use Movement Analysis
  • 6.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.6. Diagnostics Centers
    • 6.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Marker Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Competitive Scenario
      • 7.4.1.3. Regulatory Framework
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Canada Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Competitive Scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.3. Spain
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Spain Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Norway Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Competitive Scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. China Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. India Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. South Korea Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Australia Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.7.2. Mexico
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Mexico Blood Glucose Monitoring Devices Market, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company /Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List Of Key Distributors and Channel Partners
    • 8.3.2. Key Customers
    • 8.3.3. Key Company Market Share Analysis, 2025
      • 8.3.3.1. Abbott Laboratories
        • 8.3.3.1.1. Company overview
        • 8.3.3.1.2. Financial performance
        • 8.3.3.1.3. Product benchmarking
        • 8.3.3.1.4. Strategic initiatives
      • 8.3.3.2. Medtronic plc
        • 8.3.3.2.1. Company overview
        • 8.3.3.2.2. Financial performance
        • 8.3.3.2.3. Product benchmarking
        • 8.3.3.2.4. Strategic initiatives
      • 8.3.3.3. F. Hoffmann-La Roche Ltd
        • 8.3.3.3.1. Company overview
        • 8.3.3.3.2. Financial performance
        • 8.3.3.3.3. Product benchmarking
        • 8.3.3.3.4. Strategic initiatives
      • 8.3.3.4. Dexcom, Inc.
        • 8.3.3.4.1. Company overview
        • 8.3.3.4.2. Financial performance
        • 8.3.3.4.3. Product benchmarking
        • 8.3.3.4.4. Strategic initiatives
      • 8.3.3.5. Sanofi
        • 8.3.3.5.1. Company overview
        • 8.3.3.5.2. Financial performance
        • 8.3.3.5.3. Product benchmarking
        • 8.3.3.5.4. Strategic initiatives
      • 8.3.3.6. Novo Nordisk
        • 8.3.3.6.1. Company overview
        • 8.3.3.6.2. Financial performance
        • 8.3.3.6.3. Product benchmarking
        • 8.3.3.6.4. Strategic initiatives
      • 8.3.3.7. Insulet Corporation
        • 8.3.3.7.1. Company overview
        • 8.3.3.7.2. Financial performance
        • 8.3.3.7.3. Product benchmarking
        • 8.3.3.7.4. Strategic initiatives
      • 8.3.3.8. Ypsomed Holdings
        • 8.3.3.8.1. Company overview
        • 8.3.3.8.2. Financial performance
        • 8.3.3.8.3. Product benchmarking
        • 8.3.3.8.4. Strategic initiatives
      • 8.3.3.9. Glysens Incorporated
        • 8.3.3.9.1. Company overview
        • 8.3.3.9.2. Financial performance
        • 8.3.3.9.3. Product benchmarking
        • 8.3.3.9.4. Strategic initiatives
      • 8.3.3.10. Senseonics Holdings, Inc.
        • 8.3.3.10.1. Company overview
        • 8.3.3.10.2. Financial performance
        • 8.3.3.10.3. Product benchmarking
        • 8.3.3.10.4. Strategic initiatives
      • 8.3.3.11. GlucoRx Limited
        • 8.3.3.11.1. Company overview
        • 8.3.3.11.2. Financial performance
        • 8.3.3.11.3. Product benchmarking
        • 8.3.3.11.4. Strategic initiatives
      • 8.3.3.12. Zhejiang POCTech Co., Ltd
        • 8.3.3.12.1. Company overview
        • 8.3.3.12.2. Financial performance
        • 8.3.3.12.3. Product benchmarking
        • 8.3.3.12.4. Strategic initiatives
      • 8.3.3.13. i-SENS, Inc.
        • 8.3.3.13.1. Company overview
        • 8.3.3.13.2. Financial performance
        • 8.3.3.13.3. Product benchmarking
        • 8.3.3.13.4. Strategic initiatives
      • 8.3.3.14. Nemaura Medical Inc.
        • 8.3.3.14.1. Company overview
        • 8.3.3.14.2. Financial performance
        • 8.3.3.14.3. Product benchmarking
        • 8.3.3.14.4. Strategic initiatives
      • 8.3.3.15. Sinocare, Inc.
        • 8.3.3.15.1. Company overview
        • 8.3.3.15.2. Financial performance
        • 8.3.3.15.3. Product benchmarking
        • 8.3.3.15.4. Strategic initiatives
      • 8.3.3.16. Bionime
        • 8.3.3.16.1. Company overview
        • 8.3.3.16.2. Financial performance
        • 8.3.3.16.3. Product benchmarking
        • 8.3.3.16.4. Strategic initiatives
      • 8.3.3.17. AgaMatrix
        • 8.3.3.17.1. Company overview
        • 8.3.3.17.2. Financial performance
        • 8.3.3.17.3. Product benchmarking
        • 8.3.3.17.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 3. North America Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 4. North America Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 5. North America Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6. U.S. Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 7. U.S. Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 8. U.S. Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9. Canada Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 10. Canada Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 11. Canada Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12. Europe Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 13. Europe Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 14. Europe Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 15. Europe Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16. UK Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 17. UK Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 18. UK Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19. Germany Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 20. Germany Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 21. Germany Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 22. France Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 23. France Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 24. France Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25. Italy Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 26. Italy Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 27. Italy Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28. Spain Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 29. Spain Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 30. Spain Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 31. Sweden Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 32. Sweden Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 33. Sweden Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34. Norway Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 35. Norway Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 36. Norway Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37. Denmark Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 38. Denmark Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 39. Denmark Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40. Asia Pacific Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 41. Asia Pacific Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 42. Asia Pacific Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 43. Asia Pacific Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44. Japan Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 45. Japan Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 46. Japan Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47. China Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 48. China Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 49. China Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50. India Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 51. India Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 52. India Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53. Australia Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 54. Australia Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 55. Australia Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56. South Korea Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 57. South Korea Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 58. South Korea Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59. Thailand Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 60. Thailand Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 61. Thailand Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62. Latin America Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 63. Latin America Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 64. Latin America Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 65. Latin America Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66. Brazil Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 67. Brazil Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 68. Brazil Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69. Mexico Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 70. Mexico Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 71. Mexico Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72. Argentina Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 73. Argentina Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 74. Argentina Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75. MEA Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 76. MEA Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 77. MEA Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 78. MEA Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79. South Africa Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 80. South Africa Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 81. South Africa Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82. Saudi Arabia Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 83. Saudi Arabia Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85. UAE Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 86. UAE Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 87. UAE Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88. Kuwait Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 89. Kuwait Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 90. Kuwait Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews in APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews in MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Blood Glucose Monitoring Devices Market: Market Outlook
  • Fig. 14 Blood Glucose Monitoring Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration and Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Blood Glucose Monitoring Devices Market Driver Impact
  • Fig. 20 Blood Glucose Monitoring Devices Market Restraint Impact
  • Fig. 21 Blood Glucose Monitoring Devices Market Strategic Initiatives Analysis
  • Fig. 22 Blood Glucose Monitoring Devices Market: Product Movement Analysis
  • Fig. 23 Blood Glucose Monitoring Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Self-Monitoring Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 25 Blood Glucose Meter Market Estimates and Forecast, 2021 - 2033
  • Fig. 26 Traditional BGMs Market Estimates and Forecast, 2021 - 2033
  • Fig. 27 Smart BGMs Market Estimates and Forecast, 2021 - 2033
  • Fig. 28 Strips Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Lancets Market Estimates and Forecast, 2021 - 2033
  • Fig. 30 Continuous monitoring devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 31 Sensor Market Estimates and Forecast, 2021 - 2033
  • Fig. 32 Transmitter and Receiver Market Estimates and Forecast, 2021 - 2033
  • Fig. 33 Insulin pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 34 Traditional Insulin Pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 35 Smart Insulin Pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 36 Blood Glucose Monitoring Devices Market: Connectivity Movement Analysis
  • Fig. 37 Blood Glucose Monitoring Devices Market: Connectivity Outlook and Key Takeaways
  • Fig. 38 Bluetooth-Enabled Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 39 Wi-Fi-Enabled Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 40 Near Field Communication (NFC) Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 41 USB Connectivity Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 42 Blood Glucose Monitoring Devices Market: End Use Movement Analysis
  • Fig. 43 Blood Glucose Monitoring Devices Market: End Use Outlook and Key Takeaways
  • Fig. 44 Hospitals Market Estimates and Forecasts, 2021 - 2033
  • Fig. 45 Home Care Market Estimates and Forecasts, 2021 - 2033
  • Fig. 46 Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033
  • Fig. 47 Global Blood Glucose Monitoring Devices Market: Regional Movement Analysis
  • Fig. 48 Global Blood Glucose Monitoring Devices Market: Regional Outlook and Key Takeaways
  • Fig. 49 North America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 50 U.S. Market Estimates and Forecasts, 2021 - 2033
  • Fig. 51 Canada Market Estimates and Forecasts, 2021 - 2033
  • Fig. 52 Europe Market Estimates and Forecasts, 2021 - 2033
  • Fig. 53 UK Market Estimates and Forecasts, 2021 - 2033
  • Fig. 54 Germany Market Estimates and Forecasts, 2021 - 2033
  • Fig. 55 France Market Estimates and Forecasts, 2021 - 2033
  • Fig. 56 Italy Market Estimates and Forecasts, 2021 - 2033
  • Fig. 57 Spain Market Estimates and Forecasts, 2021 - 2033
  • Fig. 58 Denmark Market Estimates and Forecasts, 2021 - 2033
  • Fig. 59 Sweden Market Estimates and Forecasts, 2021 - 2033
  • Fig. 60 Norway Market Estimates and Forecasts, 2021 - 2033
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2021 - 2033
  • Fig. 62 China Market Estimates and Forecasts, 2021 - 2033
  • Fig. 63 Japan Market Estimates and Forecasts, 2021 - 2033
  • Fig. 64 India Market Estimates and Forecasts, 2021 - 2033
  • Fig. 65 Thailand Market Estimates and Forecasts, 2021 - 2033
  • Fig. 66 South Korea Market Estimates and Forecasts, 2021 - 2033
  • Fig. 67 Australia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 68 Latin America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 69 Brazil Market Estimates and Forecasts, 2021 - 2033
  • Fig. 70 Mexico Market Estimates and Forecasts, 2021 - 2033
  • Fig. 71 Argentina Market Estimates and Forecasts, 2021 - 2033
  • Fig. 72 Middle East and Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 73 South Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 74 Saudi Arabia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 75 UAE Market Estimates and Forecasts, 2021 - 2033
  • Fig. 76 Kuwait Market Estimates and Forecasts, 2021 - 2033
  • Fig. 77 Market Categorization
  • Fig. 78 Market Share of Key Market Players- Blood Glucose Monitoring Devices Market